Southwest Securities released a research report on April 24 stating that it gave HiCisco (002653.SZ) a purchase rating. The main reasons for the rating include: 1) the domestic market share of cyclopofol is 11%, and it is expected that NDA will be declare

Southwest Securities released a research report on April 24 stating that it gave HiCisco (002653.SZ) a purchase rating. The main reasons for the rating include: 1) the domestic market share of cyclopofol is 11%, and it is expected that NDA will be declared in the US in 2024; 2) HSK16149 capsules are expected to be approved for marketing in 2024Q2; 3) the HSK21542 injection application has been accepted, and the oral dosage form has entered Phase II clinical trials; 4) the innovation pipeline is progressing rapidly, and potential varieties such as NASH and PROTAC are worth looking forward to. (Mainichi Keizai Shimbun)

Zhitong FinanceApr 24 16:24

Debon Securities released a research report on April 23 stating that it gave HiCisco (002653.SZ) a purchase rating. The main reasons for the rating include: 1) the performance was in line with expectations, and Q1 revenue increased 20% year over year; 2)

Debon Securities released a research report on April 23 stating that it gave HiCisco (002653.SZ) a purchase rating. The main reasons for the rating include: 1) the performance was in line with expectations, and Q1 revenue increased 20% year over year; 2) the domestic release of cyclopofol was rapid, and internationalization progressed smoothly; 3) there are plenty of follow-up pipelines, and 12 Class 1 innovative drugs have entered the clinical stage, which ushered in the harvest period. (Mainichi Keizai Shimbun)

Zhitong FinanceApr 23 08:55

HiCisco (002653): The differentiated innovative layout has entered the harvest period, and the pipeline is rich and has great potential

Results were in line with expectations, with Q1 revenue up 20% year over year. Revenue in 2023 was $3.355 billion, 11.27% YoY. Net profit attributable to mother was 295 million yuan, 6.51% year-on-year. Non-net profit withheld from mother $242 million

德邦證券Apr 22 19:02

HiCisco (002653): Performance is in line with expectations, new product launches are progressing steadily

Incident Overview Recently, the company released the 2023 Annual Report & 2024 Quarterly Report. The 2023 revenue was 3.355 billion yuan (+11.3%), net profit due to mother was 295 million yuan (+6.5%), net profit not returned to mother

華西證券Apr 22 00:00

HiCisco (002653): HSK16149 approved, can be expected to go overseas

Incident: The company released the 2023 annual report and the 2024 quarterly report, achieving operating income of $3.355 billion (+11.27%) and net profit attributable to shareholders of listed companies of $295 million (+6.51%), and ownership

西南證券Apr 21 00:00

HiCisco (002653.SZ): Net profit of 91.9559 million yuan in the first quarter increased 219.86% year over year

On April 19, GLONGHUI (002653.SZ) released its first quarter report. Operating revenue was 752 million yuan, up 20.60% year on year, net profit of 91.9559 million yuan, up 219.86% year on year, after deducting non-net profit of 29.74 million yuan, up 4.37% year on year, with basic earnings of 0.08 yuan per share.

Gelonghui FinanceApr 19 18:06